3052 — APEX Science & Engineering Balance Sheet
0.000.00%
- TWD2.63bn
- TWD6.72bn
- TWD3.48bn
- 56
- 77
- 54
- 72
Annual balance sheet for APEX Science & Engineering, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 159 | 209 | 298 | 304 | 240 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2,817 | 3,984 | 3,991 | 4,333 | 4,568 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 7,495 | 7,039 | 7,495 | 8,727 | 7,037 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 174 | 124 | 127 | 124 | 124 |
Net Goodwill | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 8,144 | 7,556 | 8,166 | 9,374 | 7,630 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4,648 | 4,369 | 4,544 | 5,622 | 3,701 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 5,279 | 4,502 | 5,170 | 6,239 | 4,372 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 2,865 | 3,054 | 2,996 | 3,136 | 3,258 |
Total Liabilities & Shareholders' Equity | 8,144 | 7,556 | 8,166 | 9,374 | 7,630 |
Total Common Shares Outstanding |